Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach.

Sabir, Usman; Irfan, Hafiz Muhammad; Ullah, Aman; Althobaiti, Yusuf S; Asim, Mulazim Hussain

Sabir, Usman; Irfan, Hafiz Muhammad; Ullah, Aman; Althobaiti, Yusuf S; Asim, Mulazim Hussain.

Afiliación

Sabir U; Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, Punjab, Pakistan.
Irfan HM; Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, Punjab, Pakistan.
Alamgeer; Punjab University College of Pharmacy, University of the Punjab, Lahore, Punjab, Pakistan.
Ullah A; College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Althobaiti YS; Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif, Saudi Arabia.
Asim MH; Addiction and Neuroscience Research Unit, Taif University, Taif, Saudi Arabia.

J Inflamm Res ; 15: 1293-1316, 2022.

Article en En | MEDLINE | ID: mdl-35241921

Palabras clave

glutathione; inflammation; insulin resistance; non-alcoholic fatty liver disease; safranal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Inflamm Res Año: 2022 Tipo del documento: Article País de afiliación: Pakistán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google